Cellular Source of Most Common Type of Abnormal Heart Beat Found

November 2, 2009
Cardiac melanocyte-like cells in the mouse heart, identified by transgenic expression of a marker gene, are located in the region of the atria and the pulmonary veins and may serve as triggers for atrial arrhythmias. Credit: Jon Epstein, MD, Vickas Patel, MD, PhD, University of Pennsylvania School of Medicine

(PhysOrg.com) -- While studying how the heart is formed, scientists at the University of Pennsylvania School of Medicine serendipitously found a novel cellular source of atrial fibrillation (AF), the most common type of abnormal heart beat.

Jonathan Epstein, MD, William Wikoff Smith Professor, and Chair, Department of Cell and , and Vickas Patel, MD, PhD, Assistant Professor of Medicine, have identified a population of cells in the atria of the and of humans and mice that appear to be the seat of AF. The finding may lead to a more precise way to treat AF, with reduced side effects. Their findings appear online in the .

This group of cells expresses the protein DCT, which is also involved in making the melanin and in the detoxification of free radicals. The researchers also showed that the DCT-expressing cells in the mouse heart were a distinct cell type from heart-muscle cells and pigment-producing cells, although they conduct electrical currents important for coordinated contraction of the heart. The location of these cells in the pulmonary veins suggested their possible role in AF because AF can arise in these blood vessels. Atrial fibrillation is a very common and debilitating disease that greatly affects quality of life.

Know ing the location of these cells may help develop better treatments for AF. "We already target the pulmonary veins for radiofrequency ablation, a nonsurgical procedure using radiofrequency energy similar to microwaves, to treat some types of rapid heart beating as a relatively new treatment, and sometimes cure, for AF," notes Epstein.

"For the most part, current drug therapy for has been disappointingly ineffective and drug therapy is often associated with burdensome side-effects," notes Patel."

"If these cells are truly the source of AF in some patients, and we can figure out a way to identify them, then our ablation can be far more precise and targeted, thus limiting potential side effects, making the procedure potentially more simple and rapid, and hence more cost effective," explains Epstein.

But the investigators caution more research is needed to get to the point where these ideas can be validated in patients. "The findings hold out promise for a more precise cellular target for treating this common disorder," adds Epstein.

Provided by University of Pennsylvania School of Medicine (news : web)

Related Stories

Recommended for you

Key regulator of bone development identified

December 8, 2016

Loss of a key protein leads to defects in skeletal development including reduced bone density and a shortening of the fingers and toes—a condition known as brachydactyly. The discovery was made by researchers at Penn State ...

TET proteins drive early neurogenesis

December 7, 2016

The fate of stem cells is determined by series of choices that sequentially narrow their available options until stem cells' offspring have found their station and purpose in the body. Their decisions are guided in part by ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

danwalter
not rated yet Nov 05, 2009
Read about how they do it at Johns Hopkins: Google "Adventures in Cardiology"

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.